Clinical trial
Diagnostic and Risk Criteria for Complement Defects in Thrombotic Microangiopathy and Amplifying Conditions, Such as Severe Hypertension: The COMPETE Study.
NCT04745195 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Diagnostic and Risk Criteria for Complement Defects in Thrombotic Microangiopathy and Amplifying Conditions, Such as Severe Hypertension: The COMPETE Study.
- Lead sponsor
- Maastricht University Medical Center
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- August 11, 2021
- Completion date
- December 31, 2026
- Enrollment
- 42 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hemolytic uremic syndrome, atypical, hemolytic-uremic syndrome, thrombotic microangiopathies